AU2001248526A1 - Genetic manipulation of clostridium difficile - Google Patents

Genetic manipulation of clostridium difficile

Info

Publication number
AU2001248526A1
AU2001248526A1 AU2001248526A AU4852601A AU2001248526A1 AU 2001248526 A1 AU2001248526 A1 AU 2001248526A1 AU 2001248526 A AU2001248526 A AU 2001248526A AU 4852601 A AU4852601 A AU 4852601A AU 2001248526 A1 AU2001248526 A1 AU 2001248526A1
Authority
AU
Australia
Prior art keywords
clostridium difficile
genetic manipulation
genetic
manipulation
difficile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001248526A
Inventor
Michael James Elmore
Nigel Peter Minton
Katrina Maria Theresa O'Keeffe
Desmond Adrian Purdy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbiological Research Authority
Original Assignee
Microbiological Research Authority
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbiological Research Authority filed Critical Microbiological Research Authority
Publication of AU2001248526A1 publication Critical patent/AU2001248526A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU2001248526A 2000-04-07 2001-04-09 Genetic manipulation of clostridium difficile Abandoned AU2001248526A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0008682A GB0008682D0 (en) 2000-04-07 2000-04-07 Transformation of clostridium difficile
GB0008682 2000-04-07
PCT/GB2001/001612 WO2001077319A2 (en) 2000-04-07 2001-04-09 Genetic manipulation of clostridium difficile

Publications (1)

Publication Number Publication Date
AU2001248526A1 true AU2001248526A1 (en) 2001-10-23

Family

ID=9889508

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001248526A Abandoned AU2001248526A1 (en) 2000-04-07 2001-04-09 Genetic manipulation of clostridium difficile

Country Status (3)

Country Link
AU (1) AU2001248526A1 (en)
GB (1) GB0008682D0 (en)
WO (1) WO2001077319A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7473959B2 (en) 2001-06-28 2009-01-06 Samsung Electronics Co., Ltd. Non-volatile semiconductor memory devices and methods of fabricating the same
WO2008040387A1 (en) 2006-10-03 2008-04-10 Metabolic Explorer Process for chromosomal integration and dna sequence replacement in clostridia
BR122019017005B1 (en) 2011-04-22 2022-03-29 Wyeth Llc Compositions that relate to a mutant Clostridium difficile toxin
BR122016023101B1 (en) 2012-10-21 2022-03-22 Pfizer Inc Polypeptide, immunogenic composition comprising it, as well as recombinant cell derived from Clostridium difficile

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2768747B1 (en) * 1997-09-19 2000-12-01 Pasteur Institut NUCLEIC ACIDS, RECOMBINANT CELLS, AND PROCESS FOR THE PREPARATION OF IMMUNOGENIC COMPOSITIONS

Also Published As

Publication number Publication date
WO2001077319A2 (en) 2001-10-18
GB0008682D0 (en) 2000-05-31
WO2001077319A3 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
AU2001279134A1 (en) Nucleotide incorporating enzymes
AU2001280968A1 (en) Compositions and methods for directed gene assembly
AU2001253255A1 (en) Compositions and methods for inhibiting gene expression
AU5215601A (en) Inflammation-related gene
AU2002220553A1 (en) Bioreactor
AU2002214126A1 (en) Genetic analysis of microorganisms
AU2001236845A1 (en) Control of sequence of video modifying operations
AUPR041900A0 (en) Manipulation of plant cell walls
AU2001242625A1 (en) Gene sequence
AU2001270244A1 (en) Plant regulatory sequences for selective control of gene expression
AU2001248526A1 (en) Genetic manipulation of clostridium difficile
AU2001264247A1 (en) GASC1 gene
AU2002210379A1 (en) Subtilase variants
AUPQ596600A0 (en) Point of sale system
AU2001257437A1 (en) Novel cursor control system
AU2002215389A1 (en) Optimized messenger rna
AU2001285743A1 (en) Adipose-related gene
AU2001284265A1 (en) Genetic study
AU2002232078A1 (en) Clostridium difficile vaccine
AU7567101A (en) Gene expression system
AU2001231457A1 (en) Genetic locus for everninomicin biosynthesis
AU1047301A (en) Genetic switch
AU2002236595A1 (en) Enzymes
AU1292301A (en) Method for genetic manipulation
AU2002317373A1 (en) Control of gene expression